Literature DB >> 23135709

Expression of prototype foamy virus pol as a Gag-Pol fusion protein does not change the timing of reverse transcription.

Dana L Jackson1, Eun-Gyung Lee, Maxine L Linial.   

Abstract

Foamy viruses are retroviruses whose Pol protein is synthesized without Gag from a spliced mRNA. Unlike orthoretroviruses, reverse transcription occurs during viral assembly, leading to DNA-containing virions. When prototype foamy virus Pol is expressed as an orthoretroviral-like Gag-Pol fusion protein, reverse transcription also occurs late in viral replication, as measured by the timing of reverse transcriptase sensitivity to the inhibitor 3'-azido-3'deoxythymidine (AZT). Thus, timing of reverse transcription is intrinsic to Pol itself.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23135709      PMCID: PMC3554092          DOI: 10.1128/JVI.02153-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  Role of the C terminus of foamy virus Gag in RNA packaging and Pol expression.

Authors:  Carolyn R Stenbak; Maxine L Linial
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

2.  Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle.

Authors:  J Enssle; N Fischer; A Moebes; B Mauer; U Smola; A Rethwilm
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Human foamy virus reverse transcription that occurs late in the viral replication cycle.

Authors:  A Moebes; J Enssle; P D Bieniasz; M Heinkelein; D Lindemann; M Bock; M O McClure; A Rethwilm
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells.

Authors:  Yves Durocher; Sylvie Perret; Amine Kamen
Journal:  Nucleic Acids Res       Date:  2002-01-15       Impact factor: 16.971

5.  The carboxy-terminal p3Gag domain of the human foamy virus Gag precursor is required for efficient virus infectivity.

Authors:  M Zemba; T Wilk; T Rutten; A Wagner; R M Flügel; M Löchelt
Journal:  Virology       Date:  1998-07-20       Impact factor: 3.616

6.  Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new quantitative assay.

Authors:  S F Yu; M L Linial
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

7.  Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses.

Authors:  S F Yu; D N Baldwin; S R Gwynn; S Yendapalli; M L Linial
Journal:  Science       Date:  1996-03-15       Impact factor: 47.728

8.  DNA found in human immunodeficiency virus type 1 particles may not be required for infectivity.

Authors:  E J Arts; J Mak; L Kleiman; M A Wainberg
Journal:  J Gen Virol       Date:  1994-07       Impact factor: 3.891

9.  The prototype foamy virus protease is active independently of the integrase domain.

Authors:  Ralf Spannaus; Maximilian J Hartl; Birgitta M Wöhrl; Axel Rethwilm; Jochen Bodem
Journal:  Retrovirology       Date:  2012-05-10       Impact factor: 4.602

10.  The roles of Pol and Env in the assembly pathway of human foamy virus.

Authors:  D N Baldwin; M L Linial
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

View more
  4 in total

Review 1.  Foamy Virus Protein-Nucleic Acid Interactions during Particle Morphogenesis.

Authors:  Martin V Hamann; Dirk Lindemann
Journal:  Viruses       Date:  2016-08-30       Impact factor: 5.048

Review 2.  Structural and Functional Aspects of Foamy Virus Protease-Reverse Transcriptase.

Authors:  Birgitta M Wöhrl
Journal:  Viruses       Date:  2019-07-02       Impact factor: 5.048

Review 3.  Foamy virus assembly with emphasis on pol encapsidation.

Authors:  Eun-Gyung Lee; Carolyn R Stenbak; Maxine L Linial
Journal:  Viruses       Date:  2013-03-20       Impact factor: 5.048

Review 4.  Structural and functional insights into foamy viral integrase.

Authors:  Md Alamgir Hossain; Md Khadem Ali; Cha-Gyun Shin
Journal:  Viruses       Date:  2013-07-18       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.